Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Diabetes Health Center

Font Size

FDA Urged to Toughen Diabetes Drug Tests

Expert Panel Recommends More Extensive Safety Testing of New Drugs
WebMD Health News
Reviewed by Louise Chang, MD

July 3, 2008 -- Drug companies should be required to conduct stricter safety tests before marketing new diabetes drugs, expert advisors tell the FDA.

An expert committee has urged the agency to require companies to screen diabetes drugs for heart attack risk before they can be approved, or to require longer safety testing after the drugs are on the market.

The move comes after Avandia, a drug for type 2 diabetes, has come under scrutiny because of evidence it may raise heart attack risks by as much as 40%.

"We heard they wanted us to have greater certainty and assurance before approval about the cardiovascular effects of the drugs, and that they wanted us to ensure that the question was ultimately answered either before approval or after approval," says John Jenkins, who directs the FDA's Office of New Drugs. "It's a higher level of understanding and a higher level of assurance that you've excluded unacceptable cardiovascular risk."

The FDA put new warnings on Avandia last year. It was allowed to stay on the U.S. market despite calls -- including from some FDA officials -- that it be pulled from sales.

The experts' recommendations only apply to new type 2 diabetes drugs. Agency officials say they will have to decide whether to require longer safety studies before approval, more detailed follow-up trials once drugs are on the market, or both.

"It really will ultimately require us to look at each individual drug," says Mary H. Parks, MD, director of the FDA's Division of Metabolism and Endocrinology Products.

All drugs have risks. But FDA officials have not yet determined what would qualify as an "unacceptable risk" for diabetes drugs.

As many as 24 million Americans suffer from type 2 diabetes; it's a leading cause of death and disability.

Jenkins says some heart risk could be deemed acceptable if a drug is shown to be highly beneficial. Drugs with only "marginal" benefit likely won't be allowed on the market if testing shows they raise cardiovascular risks, he says.

Today on WebMD

Diabetic tools
Symptoms, diagnosis, treatment, and more.
woman flexing muscles
10 strength training exercises.
Blood sugar test
12 practical tips.
Tom Hanks
Stars living with type 1 or type 2.
kenneth fujioka, md
Can Vinegar Treat Diabetes
Middle aged person
jennie brand miller

Prediabetes How to Prevent Type 2 Diabetes
type 2 diabetes
food fitness planner